Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

BMS evaluates the potential of agonist antibodies targeting CD137 for antitumor therapy

July 24, 2003

Further positive results reported from phase Ib trial of Cancer Vac immunotherapy

July 23, 2003

Early completion anticipated for pivotal R-1549 trial

July 21, 2003

MEDI-507 proven effective in a murine model of adult T-cell leukemia

July 15, 2003

MDX-010 combined with tumor vaccines in metastatic melanoma

July 14, 2003

Multikine may enhance success of radiation and chemotherapy in H&N cancer

July 11, 2003

HuMax-CD20 effective in depleting B-cells in primate study

July 10, 2003

Alemtuzumab reported to increase clinical response and remission in refractory CLL

July 8, 2003

Treatment begins in INGN-225 phase I/II study

July 7, 2003

Phase II trial to evaluate Pentrix in prostate cancer

July 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...